−117
Taysha Gene Therapies, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−88.4
FY23:
−73.0
FY24:
−81.2
FY25:
−93.1
Change from FY21 to FY25
millions USD
FY21:
−21.6
FY22:
−24.9
FY23:
−7.35
FY24:
−0.36
FY25:
−0.60
Change from FY21 to FY25
millions USD
FY21:
39.1
FY22:
52.1
FY23:
136
FY24:
76.7
FY25:
275
millions USD
FY21:
−99.5
FY22:
−61.2
FY23:
56.0
FY24:
−4.90
FY25:
181
(positive)
Change from FY21 to FY25
millions USD
FY21:
−132
FY22:
−109
FY23:
−76.9
FY24:
−81.6
FY25:
−93.8
All amounts in millions USD